Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Merrimack Pharmaceuticals names new chief executive

By , Globe Staff

Richard Peters fills a role that’s been vacant since the October resignation of Robert Mulroy.

Eli Lilly to pay $960m for CoLucid, a Cambridge company with 7 employees

By , Globe Staff

The deal will result in the drug giant buying back an experimental migraine headache treatment discovered in Lilly’s labs and licensed to CoLucid in 2005.

Ovid opening Cambridge office to work with Takeda

By , Globe Staff

The New York biotech has struck a collaboration deal with the Japanese drug giant to work on a drug to treat rare pediatric epilepsies.

Biogen to pay rival $1.25b to settle patent dispute

By , Globe Staff

The settlement concerns an important ingredient used in Biogen’s top-selling multiple sclerosis drug.